Clinical Applications Laboratories Inc.   Report issue

For profit Phase 1
Founded: San Diego CA United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2008
NCT00626184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Clinical Applications Laboratory Inc.

Active Ingredients

Drugs in Phase 1 Trials (2)

latiglutenase (1 trial)

omeprazole (prilosec) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Celiac Disease (Phase 1)

Gastroesophageal Reflux (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2